Overfit deep neural network for predicting drug-target interactions

Summary: Drug-target interactions (DTIs) prediction is an important step in drug discovery. As traditional biological experiments or high-throughput screening are high cost and time-consuming, many deep learning models have been developed. Overfitting must be avoided when training deep learning mode...

Full description

Bibliographic Details
Main Authors: Xiao Xiaolin, Liu Xiaozhi, He Guoping, Liu Hongwei, Guo Jinkuo, Bian Xiyun, Tian Zhen, Ma Xiaofang, Li Yanxia, Xue Na, Zhang Chunyan, Gao Rui, Wang Kuan, Zhang Cheng, Wang Cuancuan, Liu Mingyong, Du Xinping
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223017236
Description
Summary:Summary: Drug-target interactions (DTIs) prediction is an important step in drug discovery. As traditional biological experiments or high-throughput screening are high cost and time-consuming, many deep learning models have been developed. Overfitting must be avoided when training deep learning models. We propose a simple framework, called OverfitDTI, for DTI prediction. In OverfitDTI, a deep neural network (DNN) model is overfit to sufficiently learn the features of the chemical space of drugs and the biological space of targets. The weights of trained DNN model form an implicit representation of the nonlinear relationship between drugs and targets. Performance of OverfitDTI on three public datasets showed that the overfit DNN models fit the nonlinear relationship with high accuracy. We identified fifteen compounds that interacted with TEK, a receptor tyrosine kinase contributing to vascular homeostasis, and the predicted AT9283 and dorsomorphin were experimentally demonstrated as inhibitors of TEK in human umbilical vein endothelial cells (HUVECs).
ISSN:2589-0042